Treatment stops the process that kills brain cells, protecting a patient’s memory Unlike other medications, the drug is cell-specific and does not have side effects The drug, known as PMN310 antibody, is effective as the brain can regenerate If successful in future trials, the medication could be available in 2025 Alzheimer’s affects around 5.5 million...